Universal Public Finance of Tuberculosis Treatment in India: An Extended Cost‐Effectiveness Analysis
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Universal public finance (UPF)—government financing of an intervention irrespective of who is receiving it—for a health intervention entails consequences in multiple domains. First, UPF increases intervention uptake and hence the extent of consequent health gains. Second, UPF generates financial consequences including the crowding out of private expenditures. Finally, UPF provides insurance either by covering catastrophic expenditures, which would otherwise throw households into poverty or by preventing diseases that cause them. This paper develops a method—extended cost‐effectiveness analysis (ECEA)—for evaluating the consequences of UPF in each of these domains. It then illustrates ECEA with an evaluation of UPF for tuberculosis treatment in India. Using plausible values for key parameters, our base case ECEA concludes that the health gains and insurance value of UPF would accrue primarily to the poor. Reductions in out‐of‐pocket expenditures are more uniformly distributed across income quintiles. A variant on our base case suggests that lowering costs of borrowing for the poor could potentially achieve some of the health gains of UPF, but at the cost of leaving the poor more deeply in debt. © 2014 The Authors. Health Economics published by John Wiley Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Economic Lives of the Poor
Banerjee, A. V., & Duflo, E. (2007) · Journal of Economic Perspectives · doi:10.1257/jep.21.1.141 · Cited by 1,703
Global health 2035: a world converging within a generation
Jamison, D. T., Summers, L. H., Alleyne, G., Arrow, K. J., Berkley, S., Binagwaho, A., Bustreo, F., Evans, D., Feachem, R. G. A., Frenk, J., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)62105-4 · Cited by 1,220
Self-citationRosenzweig, M. R., & Wolpin, K. I. (1993) · Journal of Political Economy · doi:10.1086/261874 · Cited by 1,179
Health metrics and evaluation: strengthening the science
Murray, C. J., & Frenk, J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60526-7 · Cited by 849
Fernald, L. C., Gertler, P. J., & Neufeld, L. M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60382-7 · Cited by 596 · cited 1×
“…impact on children and women.14 Finally, the framework introduced can be applied to the economic evaluation of other health policy instruments such as conditional cash transfers or financial incentives (for example Fernald et al., 2008; Banerjee et al., 2010; Lim et al., 2010; Thornton, 2008).”
BackgroundBanerjee, A. V., Duflo, E., Glennerster, R., & Kothari, D. (2010) · BMJ · doi:10.1136/bmj.c2220 · Cited by 508
COOKSON, R., DRUMMOND, M., & WEATHERLY, H. (2009) · Health Economics, Policy and Law · doi:10.1017/s1744133109004903 · Cited by 207
Cited by
Knaul, F. M., Farmer, P. E., Krakauer, E. L., De Lima, L., Bhadelia, A., Jiang Kwete, X., Arreola-Ornelas, H., Gómez-Dantés, O., Rodriguez, N. M., Alleyne, G. A. O., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32513-8 · Cited by 1,456
Self-citationGlobal health 2035: a world converging within a generation
Jamison, D. T., Summers, L. H., Alleyne, G., Arrow, K. J., Berkley, S., Binagwaho, A., Bustreo, F., Evans, D., Feachem, R. G. A., Frenk, J., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)62105-4 · Cited by 1,220
Self-citationBuilding a tuberculosis-free world: The Lancet Commission on tuberculosis
Reid, M. J. A., Arinaminpathy, N., Bloom, A., Bloom, B. R., Boehme, C., Chaisson, R., Chin, D. P., Churchyard, G., Cox, H., Ditiu, L., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30024-8 · Cited by 361
Self-citationUsing Cost-Effectiveness Analysis to Address Health Equity Concerns
Cookson, R., Mirelman, A. J., Griffin, S., Asaria, M., Dawkins, B., Norheim, O. F., Verguet, S., & J. Culyer, A. (2017) · Value in Health · doi:10.1016/j.jval.2016.11.027 · Cited by 327
Self-citationFinancial Risk Protection and Universal Health Coverage: Evidence and Measurement Challenges
Saksena, P., Hsu, J., & Evans, D. B. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001701 · Cited by 283
Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial
Verguet, S., Kim, J. J., & Jamison, D. T. (2016) · PharmacoEconomics · doi:10.1007/s40273-016-0414-z · Cited by 251
Self-citationJamison, D. T., Alwan, A., Mock, C. N., Nugent, R., Watkins, D., Adeyi, O., Anand, S., Atun, R., Bertozzi, S., Bhutta, Z., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32906-9 · Cited by 227
Self-citationNandi, A., & Shet, A. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2019.1708669 · Cited by 176
Equity impacts of price policies to promote healthy behaviours
Sassi, F., Belloni, A., Mirelman, A. J., Suhrcke, M., Thomas, A., Salti, N., Vellakkal, S., Visaruthvong, C., Popkin, B. M., & Nugent, R. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30531-2 · Cited by 165
Verguet, S., Gauvreau, C. L., Mishra, S., MacLennan, M., Murphy, S. M., Brouwer, E. D., Nugent, R. A., Zhao, K., Jha, P., & Jamison, D. T. (2015) · The Lancet Global Health · doi:10.1016/s2214-109x(15)70095-1 · Cited by 142
Self-citationAsaria, M., Griffin, S., Cookson, R., Whyte, S., & Tappenden, P. (2015) · Health Economics · doi:10.1002/hec.3058 · Cited by 125
Socioeconomic inequality in life expectancy in India
Asaria, M., Mazumdar, S., Chowdhury, S., Mazumdar, P., Mukhopadhyay, A., & Gupta, I. (2019) · BMJ Global Health · doi:10.1136/bmjgh-2019-001445 · Cited by 101
Saxena, A., Koon, A. D., Lagrada-Rombaua, L., Angeles-Agdeppa, I., Johns, B., & Capanzana, M. (2019) · Bulletin of the World Health Organization · doi:10.2471/blt.18.219980 · Cited by 72
Saxena, A., Stacey, N., Puech, P. D. R., Mudara, C., Hofman, K., & Verguet, S. (2019) · BMJ Global Health · doi:10.1136/bmjgh-2018-001317 · Cited by 58
Self-citationSalti, N., Brouwer, E., & Verguet, S. (2016) · Social Science & Medicine · doi:10.1016/j.socscimed.2016.10.020 · Cited by 45
Self-citationCommon goods for health: economic rationale and tools for prioritization
Gaudin, S., Smith, P. C., Soucat, A., & Yazbeck, A. S. (2019) · Health Systems & Reform · doi:10.1080/23288604.2019.1656028 · Cited by 39
Scaling-up essential neuropsychiatric services in Ethiopia: a cost-effectiveness analysis
Strand, K. B., Chisholm, D., Fekadu, A., & Johansson, K. A. (2016) · Health Policy and Planning · doi:10.1093/heapol/czv093 · Cited by 39
“As an addition to this analysis, an extended CEA could be performed, such that the expected non-health benefits and financial protection for the respective interventions can be evaluated (Verguet et al. 2014).”
James, E. K., Saxena, A., Franco Restrepo, C., Llorente, B., Vecino-Ortiz, A. I., Villar Uribe, M., Iunes, R. F., & Verguet, S. (2019) · Tobacco Control · doi:10.1136/tobaccocontrol-2018-054378 · Cited by 28
Self-citationVerguet, S., & Jamison, D. T. (2017) · Disease Control Priorities, Third Edition (Volume 9): Improving Health and Reducing Poverty · doi:10.1596/978-1-4648-0527-1_ch8 · Cited by 20
Self-citationPostolovska, I., Lavado, R., Tarr, G., & Verguet, S. (2018) · Health Systems & Reform · doi:10.1080/23288604.2017.1413494 · Cited by 14
Self-citationBalancing health and financial protection in health benefit package design
Lofgren, K. T., Watkins, D. A., Memirie, S. T., Salomon, J. A., & Verguet, S. (2021) · Health Economics · doi:10.1002/hec.4434 · Cited by 8
Self-citationRahayu, S. R., Susilastuti, M. S., Saefurrohim, M. Z., Azam, M., Indrawati, F., Supriyono, M., Miarso, D., Safitri, B. D., Daniswara, S., Merzistya, A. N., et al. (2023) · Ethiopian Journal of Health Sciences · doi:10.4314/ejhs.v33i1.15 · Cited by 4
Metadata
- Authors
- Verguet, S., Laxminarayan, R., & Jamison, D. T.
- Venue
- Health Economics
- Publisher
- Wiley
- Published
- 2014-02-04
- Volume
- 24
- Issue
- 3
- Pages
- 318-332
- ISSN
- 1057-9230 (ISSN-L)
- 1099-1050
- OpenAlex
- W2131309922
- Cited by
- 155
- References
- 7
- FWCI
- 47.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.